Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-15-006181

Chief Scientific Officer sold 4,250 shares at an average $18.98 ($80,644)

  • Chief Scientific Officer acquired 4,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Herman Alan C. · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2015-10-01 Exercise or conversion : show line 1 in the form +4,250 $0.42 $1,771 218,949 D
2015-10-01 Sale : show line 2 in the form −3,350 $18.83 $63,089 215,599 D
2015-10-01 Sale : show line 3 in the form −900 $19.51 $17,555 214,699 D
Open-market sales · 4,250 sh · avg $18.98 · $80,644

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-10-01 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −4,250 75,777 D
Loading xslF345X03/doc4.xml…